Indaptus Therapeutics Terminates Merger with 03 Life Sciences
Ticker: INDP · Form: 8-K · Filed: Oct 22, 2024 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger-termination, corporate-events
TL;DR
Indaptus Therapeutics just killed its merger with 03 Life Sciences, effective immediately. Deal's off.
AI Summary
On October 17, 2024, Indaptus Therapeutics, Inc. announced the termination of its previously announced merger agreement with 03 Life Sciences, Inc. The termination was effective immediately. No specific reasons for the termination were disclosed in the filing.
Why It Matters
The termination of this merger agreement could significantly impact the strategic direction and future operations of Indaptus Therapeutics, potentially affecting its stock value and investor confidence.
Risk Assessment
Risk Level: medium — The termination of a merger agreement can introduce uncertainty regarding the company's future strategy and financial stability, potentially leading to increased volatility.
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Registrant
- 03 Life Sciences, Inc. (company) — Party to terminated merger agreement
- October 17, 2024 (date) — Date of merger agreement termination
FAQ
What was the effective date of the merger agreement termination?
The termination was effective immediately as of October 17, 2024.
Which companies were involved in the terminated merger agreement?
Indaptus Therapeutics, Inc. and 03 Life Sciences, Inc. were involved in the terminated merger agreement.
What is the filing form used for this announcement?
The filing form used is a Form 8-K.
What is the principal executive office address for Indaptus Therapeutics, Inc.?
The address is 3 Columbus Circle, 15th Floor, New York, New York 10019.
What is the IRS Employer Identification Number for Indaptus Therapeutics, Inc.?
The IRS Employer Identification Number is 86-3158720.
Filing Stats: 1,214 words · 5 min read · ~4 pages · Grade level 19.9 · Accepted 2024-10-22 08:05:15
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INDP Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-041886.txt ( ) — 213KB
- indp-20241017.xsd (EX-101.SCH) — 3KB
- indp-20241017_lab.xml (EX-101.LAB) — 33KB
- indp-20241017_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2024 INDAPTUS THERAPEUTICS, INC. By: /s/ Nir Sassi Name: Nir Sassi Title: Chief Financial Officer